Taking phosphate binders may lower the risk of osteoporotic fractures in patients initiating dialysis. Oral phosphate binders may decrease the risk for osteoporotic fracture in patients starting ...

April 29, 2010 (Orlando, Florida) — Taking a proton pump inhibitor (PPI) with a phosphate binder might improve phosphorus control in patients on hemodialysis, according to a retrospective study ...

Nicotinamide and Lanthanum Carbonate and Changes in Serum Phosphate and Fibroblast Growth Factor-23 in Patients With CKD: The COMBINE Trial Inclusion criteria for this randomized, double-blind, ...

Research suggests that some compounds are safer than others with regard to skeletal complications. Hyperphosphatemia is the harbinger of numerous complications in patients with CKD, and these ...

Oral phosphate binder therapy is considered a 'tower of strength' in the ever-expanding armamentarium of drugs used to treat abnormal mineral metabolism in patients with chronic kidney disease (CKD) ...

A new report from BioTrends Research group found that the use of phosphate binders in the United States has declined in the hemodialysis and peritoneal dialysis setting over the past two years. The ...

Dissatisfaction with taking phosphate binders may influence medication adherence and ultimately clinical outcomes, according to investigators. Patients who express greater difficulty, inconvenience, ...

Please provide your email address to receive an email when new articles are posted on . Of survey respondents, 47% said large number and large size of pills were among top phosphate binder adherence ...

Trial investigated lanthanum carbonate, which has been used worldwide to treat hyperphosphatemia and has been reported to delay vascular calcification. Using a non-calcium instead of a calcium-based ...

FREMONT, Calif., Sept. 3, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with ...